Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2023-07-03 00:00:00 ET · period of report 2023-06-29 · accession 0000902664-23-003816 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-07-03 | 2023-06-29+ | LAB | JOHNSON DAVID EDWARD | 10% | J - Other | — | -779.3K | 7.80M | -9% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.001 par value per share ("Common Stock") | 2023-06-29 | J | D | 108,879 | — | 8,467,920 | I See footnote | — | — | (F1) Represents the total number of shares of Common Stock beneficially owned by Caligan Partners LP ("Caligan") following the termination of an investment management agreement with respect to an account previously managed by Caligan. (F2) The securities reported herein are held by an affiliated fund of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan. |
| 2 | Common | Common Stock | 2023-07-03 | J | D | 670,466 | — | 7,797,454 | I See footnote | — | — | (F3) This transaction represents an in-kind distribution by certain funds and accounts to which Caligan serves as the investment manager. (F2) The securities reported herein are held by an affiliated fund of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan. |